← Leaderboards
Lois Smith
Boston Children'S Hospital
$17,647,467
Attributed
$18,654,185
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,654,185 · 5
By mechanism
R01$18,256,636 · 4
R21$397,549 · 1
Top collaborators
- Zhongjie Fu4 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Zhongjie Fu$3,205,944
- Kip M Connor$3,771,658
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsRetinaNeovascularizationPreventLipidsAngiogenesisPathway InteractionsAffectRetinal DiseasesDietRetina Blood Vessel StructureRetinopathy Of PrematurityAreaOxygenDietary ControlVascular Endothelial Growth FactorsFatty AcidsNeuronsPolyunsaturated Fatty AcidsHyperglycemiaCellsGlucoseGrowthRetinal
Grant awards (38)
Dietary control of angiogenesis in retinopathy models$490,455
R01 · FY2025 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$527,318
R01 · FY2024 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$519,169
R01 · FY2023 · EY · contact PI
Glucose/lipid metabolism and vessel development in phase I ROP$442,500
R01 · FY2023 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$476,495
R01 · FY2022 · EY · contact PI
Glucose/lipid metabolism and vessel development in phase I ROP$429,225
R01 · FY2022 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$550,560
R01 · FY2021 · EY · contact PI
Glucose/lipid metabolism and vessel development in phase I ROP$429,225
R01 · FY2021 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$574,588
R01 · FY2020 · EY · contact PI
Glucose/lipid metabolism and vessel development in phase I ROP$442,500
R01 · FY2020 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$572,898
R01 · FY2019 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$177,000
R01 · FY2019 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$582,588
R01 · FY2018 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$592,898
R01 · FY2017 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$570,057
R01 · FY2015 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$570,057
R01 · FY2014 · EY · contact PI
Neuronal guidance molecules control revascularization in retinopathy$427,052
R01 · FY2014 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$552,607
R01 · FY2013 · EY · contact PI
Neuronal guidance molecules control revascularization in retinopathy$417,094
R01 · FY2013 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$542,678
R01 · FY2012 · EY · contact PI
Neuronal guidance molecules control revascularization in retinopathy$445,856
R01 · FY2012 · EY · contact PI
Dietary control of angiogenesis in retinopathy models$541,119
R01 · FY2011 · EY · contact PI
Dietary control of angiogenesis in retinopathy model; basis for clinical trials$600,670
R01 · FY2010 · EY · contact PI
Dietary control of angiogenesis in retinopathy model; basis for clinical trials$597,246
R01 · FY2009 · EY · contact PI
Dietary control of angiogenesis in retinopathy model; basis for clinical trials$585,891
R01 · FY2009 · EY · contact PI
Dietary control of angiogenesis in retinopathy model; basis for clinical trials$570,934
R01 · FY2008 · EY · contact PI
Dietary control of angiogenesis in retinopathy model; basis for clinical trials$568,330
R01 · FY2007 · EY · contact PI
Developmental Retinal Neovascularization$538,341
R01 · FY2007 · EY · contact PI
Dietary control of angiogenesis in retinopathy model; basis for clinical trials$602,113
R01 · FY2006 · EY · contact PI
Developmental Retinal Neovascularization$530,291
R01 · FY2006 · EY · contact PI
Developmental Retinal Neovascularization$532,034
R01 · FY2005 · EY
Developmental Retinal Neovascularization$521,333
R01 · FY2004 · EY
Developmental Retinal Neovascularization$580,491
R01 · FY2003 · EY
Surrogate Markers for Early Stage Diabetic Retinopathy$199,325
R21 · FY2003 · EY
RETINOPATHY OF PREMATURITY--THERAPIES AND MECHANISM$392,674
R01 · FY2002 · EY
Surrogate Markers for Early Stage Diabetic Retinopathy$198,224
R21 · FY2002 · EY
RETINOPATHY OF PREMATURITY--THERAPIES AND MECHANISM$384,933
R01 · FY2001 · EY
RETINOPATHY OF PREMATURITY--THERAPIES AND MECHANISM$377,416
R01 · FY2000 · EY